Immuno-Biological Laboratories Co., Ltd. (TSE: 4570)
Health Care · Life Sciences Tools & Services · JP
¥1,072.00
-6.38% today · +130.0% 1Y
Immuno-Biological Laboratories Co., Ltd. (TSE: 4570) operates in the Life Sciences Tools & Services industry within the Health Care sector. The company is valued at $63.05M and employs 54 people.
Over the last twelve months the share price has gained 130.0%, trading between 464.00 and 3.82K.
Tweenvest scores Immuno-Biological Laboratories Co., Ltd. across four factors: quality 75/100, value 25/100, growth 41/100, dividend 17/100. Its strongest factor is quality.
4570 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $63.05M
- Revenue (TTM)
- $6.64M
- P/E
- 27.06
- EPS
- 39.62
- Dividend yield
- 0.70%
- Beta (5Y)
- -0.06
- 52-week high
- ¥3,820.00
- 52-week low
- ¥464.00
- Avg volume (3M)
- —
- Shares outstanding
- 9.31M
- Employees
- 54
- Next earnings
- —
About Immuno-Biological Laboratories Co., Ltd.
Immuno-Biological Laboratories Co., Ltd. (IBL) is a global entity dedicated to the research, development, production, and distribution of immunological reagents. The company's diverse offerings include ELISA assay kits designed for the precise quantitative measurement of targeted substances, alongside comprehensive research support services focusing on areas such as Alzheimer's disease, metabolic syndrome, and cancer. IBL also caters to specific client needs through customized services for antibody production and the development of bespoke ELISA systems. A prominent service is LipoSEARCH, which provides tailored lipoprotein profiling and analysis utilizing gel-filtration high-performance liquid chromatography. This advanced method allows for the in-depth examination of even minute plasma or serum samples from both humans and small animals, supporting a broad spectrum of research, including lipid metabolism, the creation of pharmaceuticals for lifestyle-related diseases, functional food development, and clinical investigations. For animal health, IBL offers LipoTEST, a diagnostic and health screening tool for veterinary clinics, complemented by personalized biomarker testing services for lifestyle-related conditions. Furthermore, the company operates an innovative protein production division that leverages transgenic silkworms. This technology is instrumental in manufacturing antibodies for research and diagnostic applications, human collagen for cosmetic use, proteins for drug development, and other specialized proteins. Established in 1982, Immuno-Biological Laboratories Co., Ltd. is headquartered in Fujioka, Japan.
- ISIN
- JP3921300004
- Founded
- 1982
- Listed since
- Aug 15, 2007
- Exchange
- The Tokyo Stock Exchange
- Currency
- JPY
Other Life Sciences Tools & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| MindWalk Holdings Corp.NasdaqCM: HYFT | $70.43M | $1.55 | +3.34% |
| Xlife Sciences AGSWX: XLS | $68.02M | CHF9.80 | -4.85% |
| Champions Oncology, Inc.NasdaqCM: CSBR | $67.37M | $4.84 | -2.81% |
| Influx Healthtech LimitedNSEI: INFLUX | $64.67M | Rs270.35 | +5.61% |
| Fabtech Technologies LimitedNSEI: FABTECH | $61.19M | Rs133.22 | -6.19% |
| Pangaea Oncology, S.A.BME: PANG | $57.50M | €1.43 | 0.00% |
| Circle8 Group, Inc.NasdaqGM: CIRC | $55.22M | $0.48 | -5.45% |
| hVIVO plcAIM: HVO | $54.55M | £0.06 | 0.00% |
Figures last refreshed Oct 11, 2026.